Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro
- PMID: 20941374
- PMCID: PMC2952406
- DOI: 10.7150/ijbs.6.556
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro
Abstract
In this study the in vitro activities of seven antibiotics (ciprofloxacin, ceftazidime, tetracycline, trimethoprim, sulfamethoxazole, polymyxin B and piperacillin) and six phytochemicals (protocatechuic acid, gallic acid, ellagic acid, rutin, berberine and myricetin) against five P. aeruginosa isolates, alone and in combination are evaluated. All the phytochemicals under investigation demonstrate potential inhibitory activity against P. aeruginosa. The combinations of sulfamethoxazole plus protocatechuic acid, sulfamethoxazole plus ellagic acid, sulfamethoxazole plus gallic acid and tetracycline plus gallic acid show synergistic mode of interaction. However, the combinations of sulfamethoxazole plus myricetin shows synergism for three strains (PA01, DB5218 and DR3062). The synergistic combinations are further evaluated for their bactericidal activity against P. aeruginosa ATCC strain using time-kill method. Sub-inhibitory dose responses of antibiotics and phytochemicals individually and in combination are presented along with their interaction network to suggest on the mechanism of action and potential targets for the phytochemicals under investigation. The identified synergistic combinations can be of potent therapeutic value against P. aeruginosa infections. These findings have potential implications in delaying the development of resistance as the antibacterial effect is achieved with lower concentrations of both drugs (antibiotics and phytochemicals).
Keywords: Synergy; combination therapy; drug resistance.; phytochemicals.
Conflict of interest statement
Conflict of Interests: The authors have declared that no conflict of interest exists.
Figures




Similar articles
-
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.Yonsei Med J. 2010 Jan;51(1):111-6. doi: 10.3349/ymj.2010.51.1.111. Epub 2009 Dec 29. Yonsei Med J. 2010. PMID: 20046523 Free PMC article.
-
In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa.J Microbiol Immunol Infect. 2009 Oct;42(5):364-70. J Microbiol Immunol Infect. 2009. PMID: 20182664
-
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1995 Nov;39(11):2503-10. doi: 10.1128/AAC.39.11.2503. Antimicrob Agents Chemother. 1995. PMID: 8585734 Free PMC article. Clinical Trial.
-
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.Am J Med. 1986 Jun 30;80(6B):126-37. doi: 10.1016/0002-9343(86)90490-0. Am J Med. 1986. PMID: 3088998 Review.
-
Synergistic Hypolipidemic Effects and Mechanisms of Phytochemicals: A Review.Foods. 2022 Sep 9;11(18):2774. doi: 10.3390/foods11182774. Foods. 2022. PMID: 36140902 Free PMC article. Review.
Cited by
-
Designer Liposomic Nanocarriers Are Effective Biofilm Eradicators.ACS Nano. 2022 Oct 25;16(10):15792-15804. doi: 10.1021/acsnano.2c04232. Epub 2022 Aug 26. ACS Nano. 2022. PMID: 36018573 Free PMC article.
-
Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.Iran J Microbiol. 2016 Apr;8(2):85-92. Iran J Microbiol. 2016. PMID: 27307973 Free PMC article.
-
Characterization and Isolation of the Major Biologically Active Metabolites Isolated from Ficus retusa and Their Synergistic Effect with Tetracycline against Certain Pathogenic-Resistant Bacteria.Pharmaceuticals (Basel). 2022 Nov 26;15(12):1473. doi: 10.3390/ph15121473. Pharmaceuticals (Basel). 2022. PMID: 36558923 Free PMC article.
-
Does Protocatechuic Acid Affect the Activity of Commonly Used Antibiotics and Antifungals?Life (Basel). 2022 Jul 7;12(7):1010. doi: 10.3390/life12071010. Life (Basel). 2022. PMID: 35888098 Free PMC article.
-
Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects.Molecules. 2021 Dec 30;27(1):233. doi: 10.3390/molecules27010233. Molecules. 2021. PMID: 35011465 Free PMC article. Review.
References
-
- Mesaros N, Nordmann P, Plésiat P. et al.Pseudomonas aeruginosa: Resistance and therapeutic options at the turn of the new millennium. Clinical Microbiology and Infection. 2007;13:560–578. - PubMed
-
- Singh SB, Barrett JF. Empirical antibacterial drug discovery - Foundation in natural products. Biochemical Pharmacology. 2006;71:1006–1015. - PubMed
-
- Campbell Jr GD, Niederman MS, Broughton WA. et al.Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement. American Journal of Respiratory and Critical Care Medicine. 1996;153:1711–1725. - PubMed
-
- El Solh AA, Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia. Journal of Antimicrobial Chemotherapy. 2009;64:229–238. - PubMed
-
- Gould IM, Milne K. In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. Journal of Antimicrobial Chemotherapy. 1997;39:53–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases